AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schima, W.
Right arrow Articles by Novacek, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schima, W.
Right arrow Articles by Novacek, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Diagnosis and Staging of Pancreatic Cancer: Comparison of Mangafodipir Trisodium—Enhanced MR Imaging and Contrast-Enhanced Helical Hydro-CT

Wolfgang Schima1, Reinhold Függer2, Ewald Schober1, Claudia Oettl1, Peter Wamser2, Florian Grabenwöger1, J. Mark Ryan3 and Gottfried Novacek4

1 Department of Radiology, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
2 Department of Surgery, University of Vienna, A-1090 Vienna, Austria.
3 Department of Vascular/Interventional Radiology, Duke University Medical Center, DUMC 3808, Durham, NC 27710.
4 Department of Internal Medicine 4, Division of Gastroenterology, University of Vienna, A-1090 Vienna, Austria.



View larger version (145K):

[in a new window]
 
Fig. 1A. 44-year-old man with unresectable tumor of pancreatic body and tail. Thin-section helical CT image obtained during pancreatic phase reveals large pancreatic tumor (arrow) with tumor surrounding celiac trunk and hepatic artery.

 


View larger version (162K):

[in a new window]
 
Fig. 1B. 44-year-old man with unresectable tumor of pancreatic body and tail. Unenhanced T1-weighted gradient-recalled echo MR image shows large hypointense tumor that is not well delineated.

 


View larger version (179K):

[in a new window]
 
Fig. 1C. 44-year-old man with unresectable tumor of pancreatic body and tail. Mangafodipir trisodium—enhanced T1-weighted gradient-recalled echo MR image differentiates between hypointense tumor and enhancing normal parenchyma (solid arrow) better than B. However, extent of vascular encasement (open arrow) is better depicted by CT scan (A) than by MR images (B and C).

 


View larger version (114K):

[in a new window]
 
Fig. 2A. 50-year-old woman with small pancreatic tumor that was not revealed on CT. ERCP image shows slight narrowing of pancreatic duct (arrow) and ductal dilatation. Sphincterotomy was performed, and pancreatic stent was placed. Biopsy results were negative for tumor.

 


View larger version (148K):

[in a new window]
 
Fig. 2B. 50-year-old woman with small pancreatic tumor that was not revealed on CT. Contrast-enhanced CT scan fails to depict tumor (arrow) around stent in dilated common bile duct.

 


View larger version (145K):

[in a new window]
 
Fig. 2C. 50-year-old woman with small pancreatic tumor that was not revealed on CT. Unenhanced T1-weighted gradient-recalled echo MR image shows inhomogeneity of pancreatic head, but does not show tumor.

 


View larger version (128K):

[in a new window]
 
Fig. 2D. 50-year-old woman with small pancreatic tumor that was not revealed on CT. Mangafodipir trisodium—enhanced T1-weighted gradient-recalled echo MR image shows slight dilatation of common bile duct (long arrow) and pancreatic duct (short arrow).

 


View larger version (133K):

[in a new window]
 
Fig. 2E. 50-year-old woman with small pancreatic tumor that was not revealed on CT. Mangafodipir trisodium—enhanced MR image obtained at lower level than C and D reveals small irregular hypointense tumor (arrows) at pancreatobiliary junction. Mass was proven to be adenocarcinoma at surgery. (x2)

 


View larger version (16K):

[in a new window]
 
Fig. 3. Graph shows differentiation between benign lesions and pancreatic adenocarcinoma by receiver operating characteristic analysis. Mean area under curve is 0.832 for CT (solid line) and 0.920 for MR imaging (dotted line) (not significant).

 


View larger version (164K):

[in a new window]
 
Fig. 4A. 40-year-old man with focal pancreatitis misdiagnosed as pancreatic adenocarcinoma on MR imaging and CT. Helical CT scan shows hypoattenuating mass (straight arrow) in pancreatic head adjacent to venous confluence. Half (180° of circumference) of superior mesenteric artery is surrounded by mass (curved arrows). Adjacent CT slices (not shown) revealed no abnormalities to suggest chronic pancreatitis.

 


View larger version (143K):

[in a new window]
 
Fig. 4B. 40-year-old man with focal pancreatitis misdiagnosed as pancreatic adenocarcinoma on MR imaging and CT. Mangafodipir trisodium—enhanced T1-weighted gradient-recalled echo MR image reveals unenhancing mass (curved arrow) in pancreatic head around superior mesenteric artery. Remainder of pancreatic head (straight arrow) shows normal enhancement of parenchyma.

 


View larger version (148K):

[in a new window]
 
Fig. 5A. 68-year-old woman with focal fatty infiltration that was misdiagnosed as tumor on CT. Thin-section CT scan obtained during pancreatic phase shows small hypodense lesion (arrow) in pancreatic head adjacent to superior mesenteric vein.

 


View larger version (133K):

[in a new window]
 
Fig. 5B. 68-year-old woman with focal fatty infiltration that was misdiagnosed as tumor on CT. Unenhanced T1-weighted gradient-recalled echo MR image shows that pancreatic head is homogenous.

 


View larger version (141K):

[in a new window]
 
Fig. 5C. 68-year-old woman with focal fatty infiltration that was misdiagnosed as tumor on CT. Mangafodipir trisodium—enhanced MR image reveals homogenous uptake of mangafodipir trisodium (arrows); this finding ruled out tumor. Findings on contiguous slices (not shown) were similar. Diagnosis of focal fatty infiltration is most likely. Presence of tumor was ruled out by follow-up of patient over 2 years.

 


View larger version (158K):

[in a new window]
 
Fig. 6A. 68-year-old woman with cancer of pancreatic head and solitary liver metastasis that was missed on CT. Thin-section helical CT scan obtained during pancreatic phase shows contiguity of tumor (arrow) to lateral wall of venous confluence.

 


View larger version (124K):

[in a new window]
 
Fig. 6B. 68-year-old woman with cancer of pancreatic head and solitary liver metastasis that was missed on CT. CT image obtained during portal venous phase fails to show focal liver lesion. Contiguous slices (not shown) also failed to reveal lesion.

 


View larger version (158K):

[in a new window]
 
Fig. 6C. 68-year-old woman with cancer of pancreatic head and solitary liver metastasis that was missed on CT. Mangafodipir trisodium—enhanced T1-weighted fat-suppressed gradient-recalled echo MR image reveals hypointense mass (arrow) in pancreatic head. Ductal dilatation and atrophy of pancreatic body and tail are visible. Enhancement of atrophic parenchyma is minimal.

 


View larger version (134K):

[in a new window]
 
Fig. 6D. 68-year-old woman with cancer of pancreatic head and solitary liver metastasis that was missed on CT. Mangafodipir trisodium—enhanced gradient-recalled echo MR image reveals small subcapsular focal liver lesion (arrow). Lesion was not seen on T2-weighted MR images (not shown), which ruled out presence of cyst. All other more centrally located hypointense structures seen could be identified as portal or hepatic venous branches by reviewing contiguous slices (not shown).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.